We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Computed tomograpy evaluation of morphological changes, clinical response and survival in colorectal cancer liver metastasis treated by regorafenib: A case report.
- Authors
NOBUHISA MATSUHASHI; TAKAO TAKAHASHI; JUNKO KATO; TOSHIYUKI TANAHASHI; SATOSHI MATSUI; YOSHIYUKI SASAKI; HISASHI IMAI; YOSHIHIRO TANAKA; NAOKI OKUMURA; KAZUYA YAMAGUCHI; MANABU FUTAMURA; SHINJI OSADA; KAZUHIRO YOSHIDA
- Abstract
Pathological response to preoperative chemotherapy was recently found to be correlated with improved survival and has been proposed as a new outcome end-point following resection of liver metastases from colorectal cancer (CRC). It was demonstrated that, particularly after therapy with bevacizumab, CRC liver metastases decreased in size and underwent distinct morphological changes on computed tomography (CT). However, morphological changes in response to treatment with regorafenib have not yet been reported. A 74-year-old male patient with synchronous multiple liver and lung metastases from colon cancer was treated with regorafenib as a fifth-line therapy. CT imaging revealed a decrease in the tumor size and distinct morphological changes, namely homogeneous attenuation and sharp tumor-liver interface. The patient continued to take regorafenib for 8 months. Thus, regorafenib appeared to be effective as a last-line chemotherapy. In particular, the unique morphological changes of the metastases on CT imaging of may represent a method for evaluating the effects of CRC cancer therapy.
- Subjects
REGORAFENIB
- Publication
Molecular & Clinical Oncology, 2016, Vol 5, Issue 6, p807
- ISSN
2049-9450
- Publication type
Case Study
- DOI
10.3892/mco.2016.1045